Patents by Inventor Michael Joner

Michael Joner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Functionalized RGD peptidomimetics and their manufacture, and implant having a coating containing such functional-ized RGD peptidomimetics
    Patent number: 8961592
    Abstract: At least some embodiments of the invention relates to an implant having a coating that contains or is composed of a functionalized RGD peptidomimetic RGD-P1 having the formula (1) and/or a functionalized RGD peptidomimetic RGD-P2 having the formula (2), and an associated manufacturing method.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: February 24, 2015
    Assignee: Biotronik AG
    Inventors: Alexander Borck, Matthias Gratz, Horst Kessler, Michael Joner, Florian Rechenmacher, Stefanie Neubauer
  • FUNCTIONALIZED RGD PEPTIDOMIMETICS AND THEIR MANUFACTURE, AND IMPLANT HAVING A COATING CONTAINING SUCH FUNCTIONAL-IZED RGD PEPTIDOMIMETICS
    Publication number: 20140222134
    Abstract: At least some embodiments of the invention relates to an implant having a coating that contains or is composed of a functionalized RGD peptidomimetic RGD-P1 having the formula (1) and/or a functionalized RGD peptidomimetic RGD-P2 having the formula (2), and an associated manufacturing method.
    Type: Application
    Filed: April 14, 2014
    Publication date: August 7, 2014
    Applicant: BIOTRONIK AG
    Inventors: Alexander Borck, Matthias Gratz, Horst Kessler, Michael Joner, Florian Rechenmacher, Stefanie Neubauer
  • Functionalized RGD peptidomimetics and their manufacture, and implant having a coating containing such functionalized RGD peptidomimetics
    Patent number: 8728496
    Abstract: At least some embodiments of the invention relates to an implant having a coating that contains or is composed of a functionalized RGD peptidomimetic RGD-P1 having the formula (1) and/or a functionalized RGD peptidomimetic RGD-P2 having the formula (2), and an associated manufacturing method.
    Type: Grant
    Filed: November 9, 2011
    Date of Patent: May 20, 2014
    Assignee: Biotronik AG
    Inventors: Alexander Borck, Matthias Gratz, Horst Kessler, Michael Joner, Florian Rechenmacher, Stefanie Neubauer
  • FUNCTIONALIZED RGD PEPTIDOMIMETICS AND THEIR MANUFACTURE, AND IMPLANT HAVING A COATING CONTAINING SUCH FUNCTIONALIZED RGD PEPTIDOMIMETICS
    Publication number: 20120121658
    Abstract: At least some embodiments of the invention relates to an implant having a coating that contains or is composed of a functionalized RGD peptidomimetic RGD-P1 having the formula (1) and/or a functionalized RGD peptidomimetic RGD-P2 having the formula (2), and an associated manufacturing method.
    Type: Application
    Filed: November 9, 2011
    Publication date: May 17, 2012
    Applicant: BIOTRONIK AG
    Inventors: Alexander Borck, Matthias Gratz, Horst Kessler, Michael Joner, Florian Rechenmacher, Stefanie Neubauer
  • FUNCTIONALIZED RGD PEPTIDOMIMETICS AND THEIR MANUFACTURE, AND IMPLANT HAVING A COATING CONTAINING SUCH FUNCTIONALIZED RGD PEPTIDOMIMETICS
    Publication number: 20120121659
    Abstract: At least some embodiments of the invention relates to an implant having a coating that contains or is composed of a functionalized RGD peptidomimetic RGD-P1 having the formula (1) and/or a functionalized RGD peptidomimetic RGD-P2 having the formula (2), and an associated manufacturing method.
    Type: Application
    Filed: November 9, 2011
    Publication date: May 17, 2012
    Applicant: BIOTRONIK AG
    Inventors: Alexander Borck, Matthias Gratz, Horst Kessler, Michael Joner, Florian Rechenmacher, Stefanie Neubauer
  • COATING STENTS WITH CYCLIC RGD PEPTIDES OR MIMETICS
    Publication number: 20090053280
    Abstract: It is an object of the present invention to overcome certain disadvantages of stents, such as drug eluting stents. In particular, it is an object to provide a stent with improved re-endothelialization ability and/or simultaneous reduced rate of restenosis and/or minimal or no inflammatory potential.
    Type: Application
    Filed: May 15, 2008
    Publication date: February 26, 2009
    Inventors: Michael Joner, Horst Kessler, Renu Virmani